# A Psoriasis Plaque Test Study With LEO 90100 Cutaneous Spray, Ointment, in Psoriasis Vulgaris

> **NCT01347255** · PHASE2 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 24 (actual)

## Conditions studied

- Psoriasis Vulgaris

## Interventions

- **DRUG:** LEO90100 cutaneous spray, ointment
- **DRUG:** LEO 90100 cutaneous spray, ointment, vehicle with betamethasone dipropionate
- **DRUG:** LEO 90100 cutaneous spray, ointment, vehicle
- **DRUG:** Daivobet® ointment

## Key facts

- **NCT ID:** NCT01347255
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01347255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01347255, "A Psoriasis Plaque Test Study With LEO 90100 Cutaneous Spray, Ointment, in Psoriasis Vulgaris". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01347255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*